4 completed, 1 terminated, 1 withdrawn. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Terminated 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Von Willebrand Disease: new trials by email Literature Review of Von Willebrand Disease trials Research Report on Von Willebrand Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of IL-11 in DDAVP Unresponsive Neumega (Oprelvekin, Interleukin 11, IL-11) - Hemophilia A, Von Willebrand Disease | Phase 2 | Completed | University of Pittsburgh | 9 | 2010-01-01 | 2016-03-02 |
| Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease Biostate® - Von Willebrand Disease | Phase 2 / Phase 3 | Completed | CSL Behring | 22 | 2009-06-01 | 2017-10-03 |
| A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B ARC1779 - Von Willebrand Disease | Phase 2 | Withdrawn | Archemix Corp. | 2 | 2008-10-01 | 2009-08-21 |
| IL-11 in Adults With Von Willebrand Disease Undergoing Surgery Neumega (Oprelvekin, Interleukin 11, IL-11) - Von Willebrand Disease | Phase 2 | Terminated | Margaret Ragni | 3 | 2008-02-01 | 2019-06-11 |
| IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia Oprelvekin, Interleukin 11, IL-11 - Von Willebrand Disease | Phase 2 | Completed | Margaret Ragni | 7 | 2008-01-01 | 2018-01-31 |
| Phase II Study of IL-11 (Neumega) in Von Willebrand Disease recombinant interleukin-11 - Von Willebrand Disease | Phase 2 | Completed | University of Pittsburgh | 12 | 2004-07-01 | 2016-05-17 |
von Willebrand Diseases (6) · Hemophilia A (1) · Hemorrhage (1) · Menorrhagia (1) · Thrombosis (1)
Blood Coagulation Disorders (6) · Blood Coagulation Disorders, Inherited (6) · Blood Platelet Disorders (6) · Coagulation Protein Disorders (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6) · Genetic Diseases, Inborn (6) · Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Hemorrhagic Disorders (6) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Interleukin-11 (4) · oprelvekin (4) · ARC 1779 (1) · Factor VIII (1) · von Willebrand Factor (1)
Margaret Ragni (2) · University of Pittsburgh (2) · Archemix Corp. (1) · CSL Behring (1)
United States (4) · Bulgaria (1) · Poland (1) · Russia (1) · Ukraine (1)
Margaret V. Ragni, MD, MPH (3) · Margaret V Ragni, MD, MPH (1)
2008 (1)